An Ultra-Sensitive CRISPR-Cas12a and Aptamer-Based Biosensor Utilizing Entropy-driven Catalytic DNA Networks for Precise Detection of DNA Methyltransferase 1

Dongsheng Shen,Hong Guo,Ping Yu,Ao Li,Shu Shan,Xixi Chen,Wenjun Wu,Xiaowen Tong,Huaifang Li,Shuaikang Mei
DOI: https://doi.org/10.1016/j.talanta.2024.126267
IF: 6.1
2024-01-01
Talanta
Abstract:DNA Methyltransferase 1 (DNMT1) serves as a crucial biomarker associated with various diseases and is essential for evaluating DNA methylation levels, diagnosing diseases, and evaluating prognosis. As a result, a convenient, quantitative, and sensitive assay for detecting DNMT1 is in high demand. However, current techniques for DNMT1 detection struggle to balance accuracy, low cost, and high sensitivity, limiting their clinical usefulness. To address this challenge, we have developed a DNMT1 detection method (CAED), which combines aptamerspecific recognition with a highly programmable Entropy-driven catalysis DNA network and is further integrated with the CRISPR-Cas12a system. This innovative approach achieves a detection limit as low as 90.9 fmol/ L. To demonstrate the clinical applicability and significance of our CAED method, we successfully measured DNMT1 levels in 10 plasma samples 10 cervical tissue samples. These results underscore the potential of our method as an accurate, affordable, and ultra-sensitive tool for evaluating DNMT1 levels. This innovative method offers a potent means for assessing DNMT1 levels and significantly advances disease diagnosis and health risk prediction. Plus, it establishes an innovative design framework for CRISPR-Cas12a-based biosensors, tailored explicitly for enzyme content quantification.
What problem does this paper attempt to address?